|
Pooled analysis of two randomized phase III trials (PlanB/SuccessC) comparing six cycles of docetaxel and cyclophosphamide to sequential anthracycline taxane chemotherapy in patients with intermediate and high risk HER2-negative early breast cancer (n=5,923). |
|
|
Honoraria - Janssen Diagnostics |
Research Funding - Janssen Diagnostics |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Novartis |
Speakers' Bureau - Pfizer; Roche |
Research Funding - AstraZeneca (Inst); Chugai Pharma (Inst); Chugai Pharma (Inst); Janssen Diagnostics (Inst); Lilly (Inst); Novartis (Inst); Novartis (Inst); Sanofi/Aventis (Inst) |
Travel, Accommodations, Expenses - Pfizer |
|
|
Honoraria - Amgen; Genomic Health; Roche Pharma AG |
Consulting or Advisory Role - Amgen; Roche Pharma AG |
|
|
Honoraria - Amgen; AstraZeneca; Celgene; Novartis; Pfizer; Roche Pharma AG |
Consulting or Advisory Role - Pfizer (Inst); Roche Pharma AG (Inst) |
Research Funding - Celgene (Inst); Roche Pharma AG (Inst) |
Travel, Accommodations, Expenses - Amgen; Celgene; Roche |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Novartis; Roche |
Research Funding - Novartis |
|
|
Honoraria - AstraZeneca; Genomic Health; Novartis; Roche Pharma AG |
Consulting or Advisory Role - AstraZeneca; Genomic Health; Novartis; Roche Pharma AG |
Travel, Accommodations, Expenses - AstraZeneca; Genomic Health; Novartis; Roche Pharma AG |
|
|
Honoraria - Amgen; Celgene; Daiichi Sankyo; Novartis; Roche Pharma AG |
Consulting or Advisory Role - Roche Pharma AG |
Travel, Accommodations, Expenses - Celgene; Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Amgen; Celgene; Novartis; Pfizer; Roche |
Research Funding - Novartis (Inst) |
|
|
Honoraria - Amgen; Celgene; Genomic Health; NanoString Technologies; Novartis; Pfizer; Roche |
Consulting or Advisory Role - Celgene; Daiichi Sankyo; Lilly; Novartis; Pfizer; Roche/Genentech; Sandoz |
Research Funding - Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst) |